HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jumei Shi Selected Research

Rafoxanide

2/2020Antitumor effects of rafoxanide in diffuse large B cell lymphoma via the PTEN/PI3K/Akt and JNK/c-Jun pathways.
1/2019Rafoxanide, an organohalogen drug, triggers apoptosis and cell cycle arrest in multiple myeloma by enhancing DNA damage responses and suppressing the p38 MAPK pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jumei Shi Research Topics

Disease

30Multiple Myeloma
05/2022 - 02/2008
30Neoplasms (Cancer)
11/2021 - 02/2008
8Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2022 - 11/2015
5Lymphoma (Lymphomas)
06/2020 - 05/2016
5T-Cell Leukemia (Leukemia, T Cell)
06/2020 - 06/2014
4Hematologic Neoplasms (Hematological Malignancy)
01/2020 - 11/2016
3B-Cell Lymphoma (Lymphoma, B Cell)
06/2020 - 06/2017
2Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
08/2018 - 08/2018
2Chromosome Aberrations (Chromosome Abnormalities)
01/2015 - 06/2014
2Leukemia
06/2014 - 01/2013
1Tics (Tic)
01/2020
1Pathologic Complete Response
01/2020
1Residual Neoplasm
01/2020
1Fascioliasis
01/2019
1Inflammation (Inflammations)
01/2019
1Thrombosis (Thrombus)
01/2019
1Chromosomal Instability (Chromosome Stability)
04/2017
1Venous Thromboembolism
08/2016
1Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
05/2016
1Smoldering Multiple Myeloma
01/2015
1Proteinuria
01/2015
1Peripheral Nervous System Diseases (PNS Diseases)
01/2015
1Infections
01/2014
1Neutropenia
01/2014
1Disease Progression
01/2014
1Asthenia
01/2014
1Fatigue
01/2014
1Constipation
01/2014
1Renal Cell Carcinoma (Grawitz Tumor)
04/2013

Drug/Important Bio-Agent (IBA)

6pterostilbeneIBA
04/2020 - 11/2016
6Proteins (Proteins, Gene)FDA Link
01/2019 - 04/2013
5Pharmaceutical PreparationsIBA
01/2020 - 02/2015
4DCZ3301IBA
06/2020 - 01/2017
4Bortezomib (Velcade)FDA Link
06/2020 - 02/2008
4Histone Deacetylase InhibitorsIBA
01/2020 - 06/2014
4Proteasome InhibitorsIBA
05/2016 - 02/2008
4LigandsIBA
04/2013 - 12/2008
3PanobinostatIBA
01/2020 - 01/2015
3carfilzomibIBA
05/2016 - 06/2014
2ResveratrolIBA
05/2021 - 11/2016
2SiliconesIBA
01/2021 - 01/2020
2RafoxanideIBA
02/2020 - 01/2019
2Melphalan (Alkeran)FDA LinkGeneric
01/2020 - 12/2008
2ATPases Associated with Diverse Cellular ActivitiesIBA
01/2020 - 04/2017
2IronIBA
01/2019 - 06/2015
2Mechanistic Target of Rapamycin Complex 1IBA
08/2018 - 01/2018
25,5',6,6'- tetrachloro- 1,1',3,3'- tetraethylbenzimidazolocarbocyanineIBA
08/2018 - 11/2016
2Matrix Metalloproteinases (MMPs)IBA
07/2018 - 06/2014
2Reactive Oxygen Species (Oxygen Radicals)IBA
11/2016 - 06/2014
2VorinostatFDA Link
05/2016 - 06/2014
2HLA Antigens (Human Leukocyte Antigens)IBA
07/2014 - 02/2008
1Ribonucleotide Reductases (Ribonucleotide Reductase)IBA
05/2022
1QuercetinIBA
11/2021
1FlavonoidsIBA
11/2021
1LuciferasesIBA
05/2021
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
04/2020
1osalmideIBA
04/2020
1Therapeutic UsesIBA
01/2020
1ruxolitinibIBA
01/2020
1Type III Secretion SystemsIBA
01/2019
1InflammasomesIBA
01/2019
1p38 Mitogen-Activated Protein KinasesIBA
01/2019
1LipopolysaccharidesIBA
01/2019
1metal transporting protein 1 (ferroportin)IBA
01/2019
1Mechanistic Target of Rapamycin Complex 2IBA
08/2018
1sotrastaurinIBA
04/2018
1DCZ0358IBA
01/2018
1Cytotoxins (Cytolysins)IBA
10/2017
1Rituximab (Mabthera)FDA Link
06/2017
1DobutamineFDA LinkGeneric
12/2016
1MitogensIBA
12/2016
1Protein Kinases (Protein Kinase)IBA
11/2016
1JNK Mitogen-Activated Protein KinasesIBA
11/2016
1AntioxidantsIBA
11/2016
1Thalidomide (Thalomid)FDA Link
08/2016
1fucoidanIBA
11/2015
1ibrutinibIBA
02/2015
1CGI 1746IBA
02/2015
1CateninsIBA
02/2015
1Agammaglobulinaemia Tyrosine KinaseIBA
02/2015
1Immunoglobulin A (IgA)IBA
01/2015
1HLA-G Antigens (HLA G)IBA
07/2014
1Cytochromes c (Cytochrome c)IBA
06/2014
1Protein Isoforms (Isoforms)IBA
06/2014
1Caspase 9IBA
06/2014
1Lenalidomide (CC 5013)FDA Link
01/2014
1Itraconazole (Sporanox)FDA LinkGeneric
08/2013
1cyclopamineIBA
08/2013
1methionylmethylsulfonium chloride (MMSC)IBA
08/2013
1Messenger RNA (mRNA)IBA
04/2013

Therapy/Procedure

9Therapeutics
01/2022 - 01/2015
4Intraperitoneal Injections
04/2020 - 11/2016
2Drug Therapy (Chemotherapy)
01/2020 - 08/2018
2Stem Cell Transplantation
06/2017 - 01/2014
1Heterologous Transplantation (Xenotransplantation)
05/2019
1Radiotherapy
06/2017
1Intravenous Administration
11/2016
1Oral Administration
11/2015
1Hematopoietic Stem Cell Transplantation
01/2015
1Treatment Delay
01/2014